gastrointestinal disease

New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients

Progenity presents results on PIL Dx capsule in small intestinal bacterial overgrowth

Researchers have discovered that mast cell reactions are behind irritable bowel syndrome

Tiziana and Parexel will conduct Phase 1b/2 study of take-home capsules of Foralumab, an anti-CD3 monoclonal antibody